CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 166 enrolled
Drug / intervention
MyDiaTextother
Likely dose
Daily text messages sent to personal mobile deviceAI-extracted
Key inclusion· 4
  • Type 1 diabetes diagnosed more than 1 year ago
  • HbA1c between 8% and <14%
  • Visited diabetes clinic within last 6 months
  • Owns personal mobile device with unlimited text messaging plan
Key exclusion· 3
  • Non-English speaking
  • Significant cognitive disability or major organ illness
  • Hemolytic anemia

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02927639
NCT02927639N/ACompleted

MyDiaText: Texting the Way to Better Diabetes Control

Children's Hospital of Philadelphia·interventional·Posted Oct 7, 2016·Updated Jun 9, 2021

In Brief

A clinical study evaluating MyDiaText for Diabetes Mellitus, Type 1. Completed, enrolled 166 participants across 1 site.

Detailed Summary

To test a text messaging intervention using MyDiaText and financial incentives to determine whether such an intervention will improve self-reported self-care behaviors in children 12 to 18 years old. The intervention will consist of daily text messages sent to the subject's personal mobile device. Subjects will be incentivized to respond to text messages via a lottery financial incentive. Previously developed text messages based on the American Diabetes Association (ADA) behavior goals will be used for this intervention.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesUnited States

Timeline

N/ACompletedFinished
2017201820192020202120222023202420252026
First PostedOct 7, 2016
Enrollment StartJul 31, 2018
Primary CompletionOct 1, 2019
TodayJul 2, 2026
Enrollment to primary: 1.2 yearsPosted 9.7 years ago

Interventions

MyDiaTextother

The intervention will consist of daily text messages sent to the subject's personal mobile device.